comparemela.com

Latest Breaking News On - Respir med - Page 12 : comparemela.com

New analyses in real-world setting support the effectiveness of Fasenra in severe eosinophilic asthma

New findings from the XALOC programme support the real-world effectiveness of Fasenra (benralizumab) in the management of patients with severe eosinophilic asthma (SEA), showing reductions in annualised asthma exacerbation rate (AAER), improvements in asthma control and the ability to achieve clinical remission .

Over 480 Million People Estimated to Have COPD, World s Third Deadliest Disease, ResMed Study Reports

Correction to Lancet Respir Med 2022; published online Aug 18 https://doi org/10 1016/S2213-2600(22)00226-0

Correction to Lancet Respir Med 2022; published online Aug 18 https://doi org/10 1016/S2213-2600(22)00226-0
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

Over 480 Million People Estimated to Have COPD, World s Third Deadliest Disease, ResMed Study Reports

Over 480 Million People Estimated to Have COPD, World s Third Deadliest Disease, ResMed Study Reports
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.